Real-world outcomes versus clinical trial results of first-line immunotherapy with or without chemotherapy in patients with metastatic non-small-cell lung cancer: the CORRELATE study.

Saved in:
Bibliographic Details
Title: Real-world outcomes versus clinical trial results of first-line immunotherapy with or without chemotherapy in patients with metastatic non-small-cell lung cancer: the CORRELATE study.
Authors: Peters S; Centre Hospitalier Universitaire Vaudois, Lausanne University, Lausanne, Switzerland. Electronic address: Solange.Peters@chuv.ch., Salomonsen RJ; AstraZeneca, Gaithersburg, USA., Diaz Perez I; AstraZeneca, Gaithersburg, USA., Shcherbakova T; AstraZeneca, Cambridge, UK., Wang A; AstraZeneca, Gaithersburg, USA., Cai L; AstraZeneca, Gaithersburg, USA., Sadow S; AstraZeneca, Gaithersburg, USA., Liu SV; Division of Hematology and Oncology, Georgetown University, Washington, USA.
Source: ESMO open [ESMO Open] 2026 Jan; Vol. 11 (1), pp. 106031. Date of Electronic Publication: 2026 Jan 05.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2059-7029
DOI:10.1016/j.esmoop.2025.106031